Lloyd Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2
Closed -$414 905
2025
Q4
$414 Buy
+2
New +$400 ﹤0.01% 520
2022
Q1
Sell
-2
Closed -$296 619
2021
Q4
$0 Hold
2
﹤0.01% 432
2021
Q3
$0 Sell
2
-14
-88% -$2.39K ﹤0.01% 397
2021
Q2
$3K Sell
16
-1
-6% -$165 ﹤0.01% 338
2021
Q1
$3K Sell
17
-7
-29% -$1.2K ﹤0.01% 320
2020
Q4
$4K Hold
24
﹤0.01% 268
2020
Q3
$4K Sell
24
-2
-8% -$327 ﹤0.01% 244
2020
Q2
$4K Buy
26
+3
+13% +$471 ﹤0.01% 223
2020
Q1
$3K Hold
23
﹤0.01% 197
2019
Q4
$3K Buy
+23
New +$3.16K ﹤0.01% 276

Other funds holding FBT

Lloyd Advisory Services's FBT Position: Q1 2026 in Review

Lloyd Advisory Services sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026, closing a stake of 2 shares — an estimated $414 sold.

Lloyd Advisory Services first reported a position in FBT in Q4 2019 and held it in 10 quarters. The position peaked at $4K in Q4 2020. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Lloyd Advisory Services reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2026 after selling out during the quarter.
  • Lloyd Advisory Services sold 2 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $414.
  • Lloyd Advisory Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and held it in 10 quarters.
  • Lloyd Advisory Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4K in Q4 2020.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Lloyd Advisory Services's 13F filing for Q1 2026, filed 13 May 2026.